fbpx

Written by 08:00 Analys, Research

AGTIRA: Another grocery giant in the books

With a newly signed LOI for an Agtira Greens with Coop Nord, part of Sweden’s second largest grocery group, Agtira can add another grocery giant to the order book. With multiple deliveries on their way to ICA and a high-value LOI signed with Greenfood earlier this year, the Agtira Farming-as-a-Service business model is starting to unfold and rollout is going according to plan. The stage is now set for further expansion, with details about a long-term financing solution and new deals as the main triggers for a revaluation, and we continue to see support for a fair value of SEK 32-46 per share in 12-24 months.

Andreas Eriksson | 2022-09-06 08:00 

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and Emergers is not subject to any prohibition on dealing ahead of the dissemination of investment research. This research does not constitute investment advice and is not a solicitation to buy shares. For more information, please refer to disclaimer.  


Potential catalyst and door opener

As Coop differs from ICA in how each individual store is run, where individual ICA store owners have a lot of freedom in how to run their store, Coop is a centrally run organization. This means that with the newly signed LOI with Coop, the biggest value is perhaps not the additional SEK 4-5m of sales each year, but the fact that Agtira has managed to get their foot into Coop as an organisation. These two combined account for about 70% of total grocery sales in Sweden. Since all the previous LOI:s with ICA have been converted into firm orders we believe it is likely this will be the case also with Coop. Once a big system like Agtira Greens is operational, the pace at which Coop can order additional ones should be higher than for ICA.

Timeline for positive cash flow hinging on business model

When Agtira transformed into the foodtech company we see today, the initial business model was to be a supplier of systems, with a recurring revenue based on the AI-software PICS installed in all Agtira systems. But due to the somewhat high entry barriers this creates for the company’s clients, Agtira developed a Farming as a Service (FaaS) business model, where Agtira owns and operates the system, while the end customer undertakes to buy all goods produced for the contracted period. The latter option enables larger recurring revenue while Agtira has to finance the construction themselves, which in a large-scale rollout puts a lot of pressure on the company’s liquidity. We therefore see a financing partner as the next crucial step, which would speed up the future rollout significantly. As for now, we estimate a 50/50 distribution between FaaS and direct sales, which would result in positive EBITDA by the end of 2023. However, a shift towards a higher share of FaaS-systems would push EBITDA breakeven further into the future.

Eventful H2’22 with several triggers ahead
As Agtira now have one system (InStore) operational, two soon to be up and running (InStore in Skellefteå and Complete in Östersund), and an additional 12 in the pipeline, the recurring revenues from the FaaS-model will have an impact most likely already next year. We especially look forward to seeing the Agtira Complete in Östersund, which will give Agtira the first real life proof of concept of their aquaponic system, estimated to yield SEK 4m annually. Besides finding a financing partner, we believe news and details concerning the sites for the construction of 10 Agtira Greens from the LOI with Greenfood will be the most important triggers ahead. Combined with the strong macro trends concerning food security and the recent money flows into the foodtech sector, is now Agtira in a strong position to move forward. With a combined DCF and target multiple valuation approach, we continue to see support for a fair value of SEK 32-46 per share in 12-24 months.

DISCLAIMER

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research does not constitute investment advice and is not a solicitation to buy shares. Information provided here or on Emergers’ website emergers.se is not intended to be financial advice. This research shall not be construed as a recommendation or solicitation to invest in the companies described. Emergers cannot be held liable for either direct or indirect damages caused by decisions made on the basis of information in this analysis. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

This material is not intended to be financial advice. This material has been commissioned by the Company in question and prepared and issued by Emergers, in consideration of a fee payable by the Company. Emergers charges a standard fee for the production and broad dissemination of a detailed note following by regular update notes. Fees are paid upfront in cash without recourse. Emergers may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained herein represent those of the research analyst at Emergers at the time of publication. The company has been given the opportunity to influence factual statements before publication, but forecasts, conclusions and valuation reasoning are Emergers’ own. Forward-looking information or statements contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Emergers shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained in this material.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Emergers’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in this material may not be eligible for sale in all jurisdictions or to certain categories of investors. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

Investment in securities mentioned: Emergers has a restrictive policy relating to personal dealing and conflicts of interest. Emergers does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Emergers may have a position in any or related securities mentioned in this report, subject to Emergers’ policies on personal dealing and conflicts of interest.

Copyright: Copyright 2023 Incirrata AB (Emergers)

United Kingdom
This document is prepared and provided by Emergers for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the ”FPO”) (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States
Emergers relies upon the ”publishers’ exclusion” from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Emergers does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Read Less Read More

For new research on growth stocks, sign up to our newsletter